The goal of this clinical trial is to study whether the use of our blood culture prediction tool is non-inferior to current practice and if it can improve certain outcomes in all adult patients presenting to the emergency department with a clinical indication for a blood culture analysis (according to the treating physician). The primary endpoint is 30-day mortality. Key secondary outcomes are:
* hospital admission rates * in-hospital mortality * hospital length-of-stay. In the intervention group, the physician will follow the advice of our blood culture prediction tool.
In the comparison group all patients will undergo a blood culture analysis.
Age >= 18 years
Have a clinical indication for a blood culture analysis (according to the treating physician)
Have sufficient data recorded (laboratory results and vital sign measurements) for a prediction to be made (at least 20% of the needed parameters)
Central Venous Line (CVL) or Peripherally Inserted Central Catheter (PICC) in situ
Neutrophil count < 0.5 * 109/L
Candidemia or S. aureus bacteraemia in the past 3 months.
Most likely diagnosis of endocarditis/spondylodiscitis/infected prosthetic material